Showing results (171-180 of 286) with videos related to
Sort By:
Pageof 29
BMC Genomics|June 26, 2023
An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequencesBurcu Gurun, Wesley Horton, Dhaarini Murugan, et al.Science (New York, N.Y.)|January 11, 2003
PDGFRA activating mutations in gastrointestinal stromal tumorsMichael C Heinrich, Christopher L Corless, Anette Duensing, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Large-scale analysis of KIT aberrations in Chinese patients with melanomaYan Kong, Lu Si, Yanyan Zhu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
KIT gene mutations and copy number in melanoma subtypesCarol Beadling, Erick Jacobson-Dunlop, F Stephen Hodi, et al.Neuropathology : Official Journal of the Japanese Society of Neuropathology|August 23, 2019
A case of recurrent epilepsy-associated rosette-forming glioneuronal tumor with anaplastic transformation in the absence of therapyAaron Halfpenny, Sean P Ferris, Marjorie Grafe, et al.American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 12, 2014
Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project"Peter H O'Donnell, Keith Danahey, Michael Jacobs, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KITCharles D Blanke, George D Demetri, Margaret von Mehren, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinomaLawrence P Leichman, Bryan H Goldman, Pierre O Bohanes, et al.NPJ Precision Oncology|April 26, 2022
Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignanciesBreeshey Roskams-Hieter, Hyun Ji Kim, Pavana Anur, et al.Biorxiv : the Preprint Server for Biology|March 30, 2023
Supervised learning of high-confidence phenotypic subpopulations from single-cell dataTao Ren, Canping Chen, Alexey V Danilov, et al.Pageof 29